Launching a Global Product into the Japanese Market
Posted on November 14, 2012
By: Takao Ishida, Head of Quality and Security
Biogen Idec Japan Ltd
Introduction When considering the regulations and quality in the pharmaceutical industry there are differences in each country. As it is widely known, Japan has uniqueness and specificity. At the same time, Japan is the 2nd largest national market for pharmaceuticals representing 12% of the global m...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
insulin, pen injectors, PMDA (Pharmaceuticals and Medical Devices Agency), regulatory
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
